Utilization of the Impella for hemodynamic support during percutaneous intervention and cardiogenic shock: an insight
Nikhil Nalluria, Nileshkumar Patelb✉, Samer Saoumaa, Viswajit Reddy Anugua, Dixitha Anugulac, Deepak Astia, Varshil Mehtad, Varun M. Kumare, Varunsiri Attif, Sushruth Edlag, Rasleen K. Grewalh, Hafiz Muhammad Waqas Khana, Ritesh Kanotrai, Gregory A. Maniatisa, Ruben Kandova, James Laffertya, Michael David Dyalb, Carlos Enrique Alfonsob, Mauricio G. Cohenb
- aDepartment of cardiology, Staten Island University Hospital, New York, NY, USA
- bDepartment of cardiology, University of Miami Miller School of Medicine, Miami, FL, USA
- cDepartment of Medicine, Creighton University School of Medicine, Omaha, NE, USA
- dDepartment of Cardiology, Mount Sinai Hospital, Manhattan, NY
- eDepartment of Cardiology, Mt. Sinai St. Luke’s Roosevelt Hospital Center, New York, NY, USA
- fDepartment of Medicine, Michigan State University, Lansing, MI, USA
- gSt. John hospital and Medical Center, Cardiology, Detroit, MI, USA
- hDepartment of Medicine, Muhlenberg College, Allentown, PA, USA
- iDepartment of medicine, Banner baywood medical center, Phoenix, AZ, USA
- ✉Corresponding author
Papers open inside SciRah from the original publisher or repository; SciRah never hosts them.
Abstract
INTRODUCTION: Impella is a catheter-based micro-axial flow pump placed across the aortic valve, and it is currently the only percutaneous left ventricular assist device approved for high-risk percutaneous coronary intervention and cardiogenic shock. Areas Covered: Even though several studies have repeatedly demonstrated the excellent hemodynamic profile of Impella in high-risk settings, it remains underutilized. Here we aim to provide an up-to-date summary of the available literature on Impellas use in High risk settings as well as the practical aspects of its usage. Expert Commentary: Percutaneous coronary interventions in high rsk settings have always been challenging for a physician. Impella 2.5 and CP, have been proven safe, cost effective and feasible in High Risk Percutaneous coronary Interventions with an excellent hemodynamic profile.